St. Paul´s Hospital

Vancouver V6Z2A5

2 studies enrolling now · 15 studies all time

What they study most

Acute Kidney Injury Due to Sepsis, Acute Myocardial Infarction, Aortic Valve Disorder, Aortic Valve Insufficiency, Aortic Valve Stenosis, Chronic Cough, Coronary Artery Disease, Cystic Fibrosis, Diabetes Mellitus, Type 2, ET (Essential Thrombocythemia), Heart Failure, IPF

Studies at this site

• CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry — Recruiting now
• Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Recruiting now
• A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2) — Completed
• Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms — Running, not enrolling
• A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
• (Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI — Stopped early
• Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing — Stopped early
• Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis — Completed
• A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) — Completed
• A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF — Stopped early
• Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX — Completed
• Effects of the V1a Agonist FE 202158 in Patients With Septic Shock — Completed